Application 022542
- Type
- BLA
- Sponsor
- VIOKACE
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 022542 | Viokace | pancrelipase | 351(a) | Rx | 2026-08-01 |
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VIOKACE | PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) | TABLET;ORAL | 39,150USP UNITS;10,440USP UNITS;39,150USP UNITS | No | No |
| 002 | VIOKACE | PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) | TABLET;ORAL | 78,300USP UNITS;20,880USP UNITS;78,300USP UNITS | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Viokace | PANCRELIPASE | Aimmune Therapeutics, Inc. | 58bdb8de-582d-44e6-9b72-8d5a42fdf501 | 2025-08-14 | Warnings, Adverse reactions | BLA022542 73562-208 73562-104 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 58914-112 | Viokace | Pancrelipase | Allergan, Inc. | BLA | Current |
| 58914-112 | Viokace | Pancrelipase | Allergan, Inc. | NDA | Current |
| 58914-112 | Viokace | Pancrelipase | Allergan, Inc. | BLA | Current |
| 58914-117 | Viokace | Pancrelipase | Allergan, Inc. | BLA | Current |
| 58914-117 | Viokace | Pancrelipase | Allergan, Inc. | NDA | Current |
| 58914-117 | Viokace | Pancrelipase | Allergan, Inc. | BLA | Current |
| 73562-104 | Viokace | Pancrelipase | Nestle Healthcare Nutrition, Inc. | BLA | Current |
| 73562-104 | Viokace | Pancrelipase | Nestle Healthcare Nutrition, Inc. | BLA | Current |
| 73562-208 | Viokace | Pancrelipase | Nestle Healthcare Nutrition, Inc. | BLA | Current |
| 73562-208 | Viokace | Pancrelipase | Nestle Healthcare Nutrition, Inc. | BLA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 77669 | SUPPL | 2024-02-29 |
| 77668 | SUPPL | 2024-02-29 |
| 77657 | SUPPL | 2024-02-29 |
| 77379 | SUPPL | 2024-01-31 |
| 77378 | SUPPL | 2024-01-31 |
| 77375 | SUPPL | 2024-01-31 |
| 77374 | SUPPL | 2024-01-31 |
| 72813 | SUPPL | 2022-12-07 |
| 72806 | SUPPL | 2022-12-07 |
| 72802 | SUPPL | 2022-12-07 |
| 72201 | SUPPL | 2022-09-30 |
| 72200 | SUPPL | 2022-09-30 |
| 72183 | SUPPL | 2022-09-29 |
| 66394 | APPL | 2020-03-23 |
| 62264 | SUPPL | 2020-03-23 |
| 62227 | SUPPL | 2020-03-23 |
| 62226 | SUPPL | 2020-03-23 |
| 42555 | ORIG | 2020-03-23 |
| 38825 | ORIG | 2020-03-23 |
| 24335 | ORIG | 2020-03-23 |
| 23412 | ORIG | 2020-03-23 |
| 7515 | ORIG | 2020-03-23 |